Top 6 Companies in the Organ Preservation Market

The global organ preservation market was valued at USD 281.7 million in 2023, driven by the increasing number of organ transplant procedures. The market is expected to grow at a CAGR of 6.62% during the forecast period of 2024-2032, with the values likely to reach USD 500.2 million by 2032.

Organ preservation is an essential step in the field of organ transplantation. It entails keeping organs viable both before and after they are transplanted into a recipient and after they have been removed from a donor. The main objective is to reduce the harm that can arise from depriving an organ of its blood supply, which can occur during storage and transportation.

Techniques such as ex vivo organ perfusion, in which the organ is maintained alive and functional outside the body, possibly for prolonged periods of time, are the focus of recent advancements in organ preservation. The goals of these technologies are to reduce complications associated with ischemia-reperfusion injury and to enhance the quality and availability of organs for transplantation.

The number of individuals in need of organ transplants and the supply of appropriate donor organs differ significantly. Proper organ preservation is crucial to increase the number of transplantable organs, lower the waiting list of patients, and save more lives.

In the United States, there are over 103,000 persons on the national transplant waiting list, and 17 people pass away each day while awaiting a transplant. Although almost 46,000 transplants were carried out in 2023, a new patient is added to the waiting list every eight minutes. Up to eight lives can be saved and nearly seventy-five more can be improved by each donation. The increasing incidence of chronic illnesses such as kidney failure, liver cirrhosis, heart failure, and lung disorders has led to an increase in the number of individuals in need of organ transplants. Effective organ preservation techniques are in greater demand as the need for transplants rises in order to preserve the viability of donor organs.

Top Companies Leading the Organ Preservation Market in 2024

1. Bridge to Life Limited

Bridge to Life Limited specializes in creating and providing cutting-edge organ preservation technologies. Its primary goal is to improve organ viability and decrease ischemia by offering goods such as machine perfusion systems, cold storage solutions, and cutting-edge preservation technology. Bridge to Life Limited, a top company in organ preservation, recently shared results from its important clinical study, "Bridge to HOPE," utilizing the VitaSmart Liver Machine at the 2024 American Transplant Congress. This study examined how hypothermic oxygenated machine perfusion (HOPE) can improve outcomes in liver transplants by reducing ischemic injury and early allograft dysfunction. Furthermore, the company aims to seek FDA approval for the VitaSmart system this year, with the goal of increasing its usage in the U.S. market.

2. Avionord SRL

Avionord SRL is an Italian company that specializes in providing medical aviation services, focusing on organ transportation for transplantation, medical repatriation, and air ambulance services. Based in Milan, Avionord runs a collection of specially designed aircraft for quick and secure transportation of organs and medical staff, guaranteeing timely delivery for transplant surgeries. In 2024, Avionord SRL partnered with Manta Aircraft to improve organ preservation and transport with the creation of the ANN eVTOL platform, a hybrid-electric aircraft specifically for medical use.

3. Carnamedica S.P.

Carnamedica S.P. is a medical company based in Poland, established in the year 2000, which specializes in manufacturing and distributing medical equipment and devices. The company is recognized for its dedication to high-quality standards and customer service and has a variety of healthcare offerings, such as diagnostic equipment, therapy aids, and medical furniture. Based in Poland, Carnamedica provides services to multiple healthcare institutions throughout Europe. It provides cutting-edge blood preservation solutions created to uphold the quality and viability of blood and its components throughout storage and transportation. These solutions comply with global standards, guaranteeing safety and effectiveness for transfusion and medical purposes.

4. Dr. Franz Köhler Chemie GmbH

Dr. Franz Köhler Chemie GmbH, a research-oriented and pioneering pharmaceutical company, is currently in its third generation and has over 200 employees at its facilities in Bensheim and Alsbach, Germany. Dr. Franz Josef Köhler established the company in 1959. The company has recently dedicated its efforts to enhancing organ preservation solutions, with a specific focus on the advancement of a Histidine-Tryptophan-Ketoglutarate (HTK) solution.

5. Shanghai Genext Medical Technology Co., Ltd.

Shanghai Genext Medical Technology Co., Ltd., established in 2003 in China, focuses on manufacturing medical devices, transplant medications, and diagnostic equipment. Based in Shanghai, it offers therapeutic drug monitoring, healthcare solutions, and supply chain management services in China and globally. 

Lately, the company has been making progress in its research on blood preservation technologies, with a focus on creating new storage solutions that prolong the lifespan of blood components while they are being transported and stored. This ensures that the blood is safe and effective for medical purposes. 

6. Transplant Biomedicals S.L

Transplant Biomedicals S.L., established in 2014 in Barcelona, Spain, is dedicated to creating cutting-edge medical equipment for the preservation of organs, tissues, and cells. The goal of the company is to enhance the survival and functionality of preserved biological materials to improve transplant outcomes.

Transplant Biomedicals has recently created new technologies to enhance the preservation of organs during transport, which aids in lowering the chances of delayed graft function. They are currently engaged in developing advanced solutions to improve the conditions for storing organs and tissues.